RAD BioMed

CVAid Medical focuses on developing an artificial intelligence-based platform aimed at enhancing stroke detection and triage. This technological solution is designed to improve the diagnosis of strokes, ultimately saving lives by facilitating early intervention. The company's approach encompasses the entire process, starting from pre-hospital early diagnosis, through in-hospital management, and extending to follow-up care after discharge. By providing tools that assist both physicians and patients, CVAid Medical aims to improve treatment outcomes through timely and effective stroke management.

BELKIN Laser Ltd. is an innovative company based in Yavne, Israel, founded in 2013, that focuses on developing a groundbreaking one-second laser device for the treatment of glaucoma. This automated device aims to provide ophthalmologists with a means to deliver drop-less and contactless care, addressing the significant disparity between the large number of glaucoma patients, estimated at 67 million, and the relatively limited number of ophthalmologists available. The technology is particularly relevant for Open Angle Glaucoma, which affects 70% of glaucoma patients, and has the potential to pioneer treatment for Angle Closure Glaucoma, notably prevalent among Asian populations. BELKIN's solution is designed to be non-invasive, instantaneous, and painless, offering a patient-friendly alternative to traditional methods. By simplifying the treatment process, BELKIN Laser seeks to transform glaucoma care from a specialized procedure to a widely accessible option that can be performed by all ophthalmologists and healthcare providers, thereby enhancing patient access to essential care.

Vectorious Medical Technologies Ltd. is a medical device company based in Tel Aviv, Israel, founded in 2011. The company specializes in developing innovative cardiac monitoring systems for patients with congestive heart failure. Its flagship product, the V-LAP, is a pioneering in-heart microcomputer that monitors left atrial pressure (LAP), a key indicator for heart failure deterioration. This digital, wireless, and battery-less sensory implant offers daily push-button readings, allowing for timely and effective interventions. Vectorious is actively conducting clinical studies in Europe, including countries like Italy, Germany, and the UK, to obtain regulatory approval. The company aims to enhance the quality of life and life expectancy for heart failure patients through its advanced monitoring technology.

SoftWheel develops advanced in-wheel suspension technology tailored for the wheelchair, bicycle, and automotive industries. Based in Tel Aviv, Israel, the company was founded in 2011 and focuses on creating innovative solutions that enhance mobility. Its product offerings include suspension arms and wheel rims, which are distributed through a network of resellers both domestically and internationally. SoftWheel has established strategic partnerships with notable companies in the industry, further enhancing its market presence. The company's mission is to improve transportation for individuals and industries reliant on wheeled mobility, reflecting its commitment to fostering a better environment and enhancing user experience.

Advanced Ophthalmic Pharma Ltd., a biomedical company, develops technologies in ophthalmology. It offers Eye AdMister, a drug delivery device, enables the mist application of preservative-free ophthalmic drug formulations for eye care. The company was founded in 2007 and is based in Tel Aviv, Israel.